Home > Financial Ratios > THEMIS MEDICARE

THEMIS MEDICARE
Core EBITDA Growth

    Back to All Ratios
THEMIS MEDICARE is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for THEMIS MEDICARE
Please provide your vote to see the results

THEMIS MEDICARE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -28.74-22.7392.3735.77690.93

What is the latest Core EBITDA Growth ratio of THEMIS MEDICARE ?

The latest Core EBITDA Growth ratio of THEMIS MEDICARE is -28.74 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-28.74
Mar2023-22.73
Mar202292.37
Mar202135.77
Mar2020690.93

How is Core EBITDA Growth of THEMIS MEDICARE Trending?

Years Core EBITDA Growth % Change
Mar2024 -28.74
Negative
Mar2023 -22.73
Negative
Mar2022 92.37
158.23
Mar2021 35.77
-94.82
Mar2020 690.93 -

Other Financial Ratios of THEMIS MEDICARE


Compare Core EBITDA Growth ratio of peers of THEMIS MEDICARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
THEMIS MEDICARE ₹932.4 Cr -9.1% -18.6% -55.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,115.0 Cr 3.5% -3.4% -5.8% Stock Analytics
DIVIS LABORATORIES ₹162,735.0 Cr 3.7% -10.2% 25.6% Stock Analytics
CIPLA ₹126,313.0 Cr 5.3% 6.1% -1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,592.0 Cr 1.4% 4.6% 7.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,095.0 Cr 3.9% 0% -9.9% Stock Analytics


THEMIS MEDICARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
THEMIS MEDICARE

-9.1%

-18.6%

-55.1%

SENSEX

-0%

-2.4%

1.2%


You may also like the below Video Courses